Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma
about
cfDNA analysis from blood in melanomaDetection of Circulating BRAF(V600E) in Patients with Papillary Thyroid CarcinomaDramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?The Future of Molecular Analysis in Melanoma: Diagnostics to Direct Molecularly Targeted Therapy.Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.Circulating BRAFV600E levels correlate with treatment in patients with thyroid carcinoma.A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review.
P2860
Q26772199-8F683612-4994-4AE3-B77B-69B8D5664488Q36468764-20AC74B4-1174-4683-B93C-D43D8A718A57Q36887654-2356E6D5-914B-407B-BF95-0633D56BEAE4Q37171015-B9F4502C-19FF-4372-AB09-5053DC9987FFQ37242412-F0374261-ABE1-4F34-A5FF-788FD7A66C01Q38620826-13CB5AE8-A177-497E-906B-5D35BF792795Q39292740-4900CE6E-F1E1-42D2-971A-5E2D4346E12FQ46721978-9145EE84-EAF6-4923-A415-492EAC87A17DQ49600551-615731E1-5A51-4573-9C98-557839EE0ADBQ52714320-DB6D297C-C662-4F1C-BCFD-BED26EB61577Q55101444-98934DBB-28A0-4BA5-BD78-3B38E388997C
P2860
Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Clinical utility of a blood-based BRAF
@nl
Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma
@ast
Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma
@en
type
label
Clinical utility of a blood-based BRAF
@nl
Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma
@ast
Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma
@en
prefLabel
Clinical utility of a blood-based BRAF
@nl
Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma
@ast
Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma
@en
P2093
P2860
P1476
Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma
@en
P2093
A John Iafrate
Aislyn P Schalck
Alexander Carlson
Alireza Sepehr
Anasuya Gunturi
Anita Giobbie-Hurder
David F McDermott
David J Panka
Dennie Fredrick
Donald P Lawrence
P2860
P304
P356
10.1158/1535-7163.MCT-14-0349
P577
2014-10-15T00:00:00Z